Market Overview:
The global cytology and HPV testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cervical cancer, technological advancements in cytology and HPV testing, and rising demand for early diagnosis and treatment of cervical cancer. The global cytology and HPV testing market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into systems, assay kits, services. The systems segment is expected to account for the largest share of the global cytology and HPV testing market in 2018 owing to its growing demand for early diagnosis and treatment of cervical cancer.
Product Definition:
Cytology is the study of cells, their structure and function. HPV testing is a lab test that looks for human papillomavirus (HPV) DNA in cervical cells. HPV is the virus that can cause cervical cancer.
Systems:
The global systems, it's usage and growth factor in cytology and HPV testing market was valued at USD 4.6 billion in 2015. It is expected to grow with CAGR of XX% over the forecast period. The increasing prevalence of cancer globally is one of the major factors driving demand for diagnostic techniques such as cytology and HPV testing over the forecast period.
Assay Kits:
An assay kit is a collection of reagents and instruments that are used for the detection of specific antibodies or antigens in biological fluids. The most commonly used assay kits in cytology and HPV testing include Immunohistochemical (IHC) Kit, Enzyme-linked Immunosorbent Assay (ELISA) Kit, Magnetic Beads Assay System (MBAS), flow cytometry, western blotting and others.
Application Insights:
Based on application, the global market is segmented into hospitals, clinics and research institutes. Hospitals held the largest share in 2017 owing to increasing prevalence of cancer and growing need for cytology testing services. Moreover, an increase in number of cytology laboratories has also contributed to overall market growth.
Clinics are expected to be fastest-growing application segment over the forecast period due to rising demand for HPV tests by GYNs as well as general physicians. Increasing awareness about preventive healthcare along with rising availability of advanced diagnostic techniques is further anticipated to boost product demand globally over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in research and development, and increasing awareness about HPV testing. The Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing government initiatives for cancer screening programs coupled with rising disposable income levels especially in developing countries such as India and China. Moreover, an increase in demand for cytology services due to growing population is anticipated fuel regional growth during the forecast period.
The key factors that are likely to impact growth include economic conditions; availability & accessibility of tests; technological advancements; marketing strategies adopted by companies; funding activities undertaken by public agencies along with other macro-economic factors affecting individual countries within each region may affect overall regional growth rates.
Growth Factors:
- Increasing incidence of cervical cancer: The incidence of cervical cancer is increasing at a fast pace across the globe. This is mainly due to the rising prevalence of HPV infection. According to the World Health Organization (WHO), there were an estimated 528,000 new cases and 266,000 deaths from cervical cancer in 2012. Cervical cancer is one of the most common cancers among women worldwide and accounts for nearly 10% of all female cancers diagnosed each year.
- Growing awareness about HPV and its association with cervical cancer: There is growing awareness among people about HPV and its association with cervical cancer. This has led to an increase in demand for cytology and HPV testing services across the world. In addition, governments are also investing in programs aimed at raising awareness about HPV infection and its prevention methods, which will further boost demand for cytology and HPV testing services in years to come.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cytology and HPV Testing Market Research Report
By Type
Systems, Assay Kits, Services
By Application
Hospitals, Clinics, Research Institutes
By Companies
Abbott, Arbor Vita, Becton Dickinson, Cepheid, Roche, Fujirebio, Hologic, OncoHealth, QIAGEN
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Cytology and HPV Testing Market Report Segments:
The global Cytology and HPV Testing market is segmented on the basis of:
Types
Systems, Assay Kits, Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Arbor Vita
- Becton Dickinson
- Cepheid
- Roche
- Fujirebio
- Hologic
- OncoHealth
- QIAGEN
Highlights of The Cytology and HPV Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Systems
- Assay Kits
- Services
- By Application:
- Hospitals
- Clinics
- Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cytology and HPV Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cytology is a term used to describe the examination of cells. HPV testing is a type of cytology that can be used to screen for the presence of human papillomavirus (HPV).
Some of the key players operating in the cytology and hpv testing market are Abbott, Arbor Vita, Becton Dickinson, Cepheid, Roche, Fujirebio, Hologic, OncoHealth, QIAGEN.
The cytology and hpv testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cytology and HPV Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cytology and HPV Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cytology and HPV Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cytology and HPV Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cytology and HPV Testing Market Size & Forecast, 2020-2028
4.5.1 Cytology and HPV Testing Market Size and Y-o-Y Growth
4.5.2 Cytology and HPV Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Systems
5.2.2 Assay Kits
5.2.3 Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cytology and HPV Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cytology and HPV Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Systems
9.6.2 Assay Kits
9.6.3 Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Systems
10.6.2 Assay Kits
10.6.3 Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Systems
11.6.2 Assay Kits
11.6.3 Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Systems
12.6.2 Assay Kits
12.6.3 Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Systems
13.6.2 Assay Kits
13.6.3 Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cytology and HPV Testing Market: Competitive Dashboard
14.2 Global Cytology and HPV Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Arbor Vita
14.3.3 Becton Dickinson
14.3.4 Cepheid
14.3.5 Roche
14.3.6 Fujirebio
14.3.7 Hologic
14.3.8 OncoHealth
14.3.9 QIAGEN
